 |
市場調査レポート
商品コード
1244323
甲状腺機能検査の世界市場 - 市場規模、シェア、成長分析：タイプ別、最終用途別、産業予測（2022年～2028年）Global Thyroid Function Test Market Size, Share, Growth Analysis, By Type(TSH tests, T3 tests), By End-use(Hospitals, Research laboratories) - Industry Forecast 2022-2028 |
||||||
| 甲状腺機能検査の世界市場 - 市場規模、シェア、成長分析：タイプ別、最終用途別、産業予測（2022年～2028年） |
|
出版日: 2022年11月26日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の甲状腺機能検査の市場規模は、2021年は16億8,000万米ドルで、2022年～2028年の予測期間中に6.22%以上のCAGRで成長し、2028年には25億6,000万米ドルに達すると予測されています。市場の成長を後押しする主な要因には、特に女性の甲状腺機能低下症や甲状腺機能亢進症などの甲状腺疾患の増加、高齢化の進展などが挙げられます。
当レポートでは、世界の甲状腺機能検査市場を調査しており、市場の概要、市場規模や予測、促進要因・抑制要因、タイプ別・最終用途別・地域別の分析など包括的な情報を提供しています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
- 調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と限界
- 親市場分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- 主要投資分析
- 主な成功要因
- 競合の程度
- 市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーターの分析
- 競争企業間の敵対関係
- 代替製品の脅威
- 買い手の交渉力
- 新規参入業者の脅威
- 供給企業の交渉力
- 将来の混乱に関するSkyquestの特別な洞察
- 政治的影響
- 経済的影響
- 社会的影響
- 技術的影響
- 環境的影響
- 法的影響
- 世界の甲状腺機能検査市場：タイプ別
- 市場概要
- TSH検査
- T3検査
- T4検査
- その他
- 世界の甲状腺機能検査市場：最終用途別
- 市場概要
- 病院
- 研究ラボ
- 診断ラボ
- その他
- 世界の甲状腺機能検査市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
- 競合情勢
- 主要５社の比較
- 2021年の主要企業の市場ポジショニング
- 主要な市場企業が採用した戦略
- 主要成功戦略
- 開発別
- 会社別
- 年別
- 市場における最近の活動
- 主要企業の市場シェア、2021年
- 主な企業プロファイル
- Thermo Fisher
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
- Abbott
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
- Roche
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
- Danaher
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
- Danaher
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
- Kronus（米国）
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
- Merck
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
- Cortez Diagnostics
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
- BioMerieux
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
- Qualigen
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
- Auto bio-Diagnostics
- 会社概要
- 事業セグメント概要
- 財務アップデート
- 主な発展
Thyroid Function Test Market size was valued at USD 1.68 billion in 2021, and it is expected to reach a value of USD 2.56 billion by 2028, at a CAGR of more than 6.22% over the forecast period (2022- 2028).
The thyroid function test is a diagnostic procedure used to evaluate the condition of the thyroid gland, a vital organ that regulates growth and metabolism. The test analyzes the blood's levels of several hormones, including T3, T4, and thyroid-stimulating hormone (TSH).
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Thyroid Function Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report
The global thyroid function test market is segmented based on the type, end user and region. Based on the type, Thyroid Function Test Market is segmented into TSH tests, T3 tests, T4 tests, and Other. Based on end user, Thyroid Function Test Market is segmented hospitals, research laboratories, diagnostic laboratories, and others. Based on region Thyroid Function Test Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Driver
Particularly in women, thyroid disorders such hypothyroidism and hyperthyroidism are becoming more common. Thyroid function tests are becoming more popular to detect and track these conditions as a result. The world's aging population, and older individuals are more likely to have thyroid diseases. The need for thyroid function testing is expected to go up in the coming years as a result of this demographic trend. Thyroid function testing has benefited greatly by technological developments such as the development of automated immunoassay devices. The tests are now more precise and efficient, increasing demand for the market.
Restraint
Endocrinologists and laboratory technicians is skilled professionals that can perform and interpret thyroid function testing. Such professionals are in short supply in many areas, which can limit market expansion. For some patients, particularly those who are in developing nations, the expense of thyroid function tests may be insurmountable. It might decrease the need for these tests in some regions. The cost of thyroid function testing is frequently not fully covered by healthcare systems, which may restrict certain patients' access.
Market Trends
The thyroid function test market is seeing a rise in the use of point-of-care testing, which enables quick and precise testing at the point of care. The demand for testing choices that are quicker and more practical is what is driving this development. The market for thyroid function tests is seeing an increase in personalised medicine, which entails treating each patient according to their specific characteristics. As we learn more about the genetic and molecular pathways driving thyroid problems, this tendency is becoming more prevalent. Thyroid function testing at home is growing in popularity along with telemedicine and remote patient monitoring. More practical testing choices are required, especially in rural or remote areas, that is driving this trend.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Thyroid Function Test Market by Type
- Market Overview
- TSH tests
- T3 tests
- T4 tests
- Other
- Global Thyroid Function Test Market by End-use
- Market Overview
- Hospitals
- Research laboratories
- Diagnostic laboratories
- Others
- Global Thyroid Function Test Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Thermo Fisher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- DiaSorin (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kronus (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cortez Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qualigen (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Auto bio-Diagnostics (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
